May 15, 2012 |
Stelic will have two presentations below about our STAM model in DDW 2012, San Diego.
“A Novel Murine Model Recapitulates the Pathogenesis of Human
Non-alcoholic Steatohepatitis (NASH) and NASH-related Hepatocellular Carcinoma”
“Effects of Telmisartan on a Murine Model of Non-alcoholic
steatohepatitis (NASH) and NASH-related Hepatocellular Carcinoma”
|
|---|---|
Aug 22, 2011 |
“News and Education”, new website contents about research and development of NASH are released.
|
Nov 18, 2010 |
Data from pharmacological studies with STAM mice were published at an international conference "NASH 2010": the Ninth JSH Single Topic Conference.
|
Jul 30, 2010 |
Stelic signed collaborative research agreement with Hokkaido University in carbohydrate research field.
|
May 10, 2010 |
Stelic launched new contracting service "Liver histology scoring".
|
Dec 24, 2009 |
Received top-grade grant from JST
Subject：“The development of RNA interference-based therapeutics for Crohn's disease stricture.”
JST; Japan Science and Technology Agency
|
Aug 27, 2009 |
Received grant from NEDO : “Grant for Application of Industrial Technology Innovation”.
|
Jul 02, 2009 |
Stelic won cum laude recognition for a poster presentation in the 17th Japan Digestive Disease Week 2009(JDDW 2009). - Kyoto: Thursday, October 15, 2009
Subject：“Establishment of a novel NASH model mice representative human pathological condition”
|
Apr 01, 2009 |
Stelic announced the launch of contracting services for hepatic cancer (HCC) therapeutic evaluation, using Stelic’s novel NASH-HCC Mouse Model.
|
